Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
155.4 USD | -0.73% | +19.54% | -13.21% |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.21% | 16.36B | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.40% | 22.18B | |
-16.67% | 21.2B | |
-9.42% | 18.31B | |
-38.74% | 17.38B | |
+5.41% | 13.97B | |
+33.57% | 12.17B | |
+305.27% | 8.32B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- Adaptive Biotechnologies Partners With BeiGene on Minimal Residual Disease Testing of Potential Treatments for Lymphoid Malignancies